{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:10:09Z","timestamp":1756660209956,"version":"3.44.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpedhc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Health Care"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.pedhc.2025.03.008","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T07:37:39Z","timestamp":1744702659000},"page":"811-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dissolved Bictegravir\/Emtricitabine\/Tenofovir Alafenamide Improves Medication Adherence"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0505-3545","authenticated-orcid":false,"given":"Matthew J.","family":"Grant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pedhc.2025.03.008_bib0001","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0000000000002142","article-title":"Antiretroviral adherence level necessary for HIV viral suppression using real-world data","volume":"82","author":"Byrd","year":"2019","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"5","key":"10.1016\/j.pedhc.2025.03.008_bib0002","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/S2352-3018(24)00007-9","article-title":"Expanding options of child-friendly, single-tablet regimens for young children with HIV","volume":"11","author":"Cressey","year":"2024","journal-title":"Lancet HIV"},{"key":"10.1016\/j.pedhc.2025.03.008_bib0003","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2147\/PPA.S268499","article-title":"Impact of medication regimen simplification on medication adherence and clinical outcomes in patients with long-term medical conditions","volume":"14","author":"Elnaem","year":"2020","journal-title":"Patient Preference and Adherence"},{"issue":"8","key":"10.1016\/j.pedhc.2025.03.008_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22818","article-title":"Complexity of medication regimens for children with neurological impairment","volume":"4","author":"Feinstein","year":"2021","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.pedhc.2025.03.008_bib0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/1060028020953631","article-title":"Successful bictegravir\/emtricitabine\/tenofovir alafenamide treatment in a HIV patient with swallowing difficulties","volume":"55","author":"Ferr\u00e1ndez","year":"2021","journal-title":"Annals of Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.pedhc.2025.03.008_bib0006","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s11606-019-04958-z","article-title":"A mixed methods evaluation of an inclusive sexual history taking and HIV prevention curriculum for trainees","volume":"34","author":"Frasca","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"7","key":"10.1016\/j.pedhc.2025.03.008_bib0007","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/ajhp\/zxaa017","article-title":"Crushed bictegravir\/emtricitabine\/tenofovir alafenamide in a human immunodeficiency virus\u2013positive patient with esophageal cancer","volume":"77","author":"Fulco","year":"2020","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"5","key":"10.1016\/j.pedhc.2025.03.008_bib0008","first-page":"793","article-title":"Promoting medication adherence in children","volume":"74","author":"Gardiner","year":"2006","journal-title":"American Family Physician"},{"issue":"1","key":"10.1016\/j.pedhc.2025.03.008_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jac\/dkac369","article-title":"Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: The SOLUBIC randomized crossover study","volume":"78","author":"Hocqueloux","year":"2022","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"8","key":"10.1016\/j.pedhc.2025.03.008_bib0011","doi-asserted-by":"crossref","first-page":"783","DOI":"10.5863\/1551-6776-26.8.783","article-title":"Antiretroviral therapy in children and adolescents: A look into modern single tablet regimens","volume":"26","author":"Lee","year":"2021","journal-title":"Journal of Pediatric Pharmacology and Therapeutics"},{"key":"10.1016\/j.pedhc.2025.03.008_bib0012","unstructured":"Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (n.d.). Guidelines for the use of antiretroviral agents in pediatric HIV infection.https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/pediatric-arv\/guidelines-pediatric-arv.pdf."},{"issue":"3","key":"10.1016\/j.pedhc.2025.03.008_bib0013","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3851\/IMP1534","article-title":"Treating an HIV-infected paediatric patient: An easy task?","volume":"15","author":"Rakhmanina","year":"2010","journal-title":"Antiviral Therapy"},{"issue":"1","key":"10.1016\/j.pedhc.2025.03.008_bib0014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/09564624211048702","article-title":"Crushed bictegravir\/emtricitabine\/tenofovir alafenamide in a human immunodeficiency virus-positive patient with pancreatic cancer","volume":"33","author":"Roa","year":"2022","journal-title":"International Journal of STD and AIDS"},{"issue":"5","key":"10.1016\/j.pedhc.2025.03.008_bib0015","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1016\/S2352-3018(23)00327-2","article-title":"Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: A phase 2\/3, open-label, single-arm study","volume":"11","author":"Rodriguez","year":"2024","journal-title":"Lancet HIV"},{"issue":"4","key":"10.1016\/j.pedhc.2025.03.008_bib0016","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/phar.1728","article-title":"Impact of pill burden on adherence, risk of hospitalization, and viral suppression in patients with HIV infection and AIDS receiving antiretroviral therapy","volume":"36","author":"Scott Sutton","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pedhc.2025.03.008_bib0017","unstructured":"ViiV Healthcare. (2022). Viiv healthcare announces US FDA approval of triumeq PD, the first dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV. https:\/\/viivhealthcare.com\/en-us\/media-center\/news\/press-releases\/2022\/march\/viiv-healthcare-announces-us-fda-approval\/"},{"issue":"9","key":"10.1016\/j.pedhc.2025.03.008_bib0018","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/QAD.0000000000002885","article-title":"Pediatric liquid \u201csingle tablet regimens\u201d for HIV-a call to action","volume":"35","author":"Winslow","year":"2021","journal-title":"AIDS"}],"container-title":["Journal of Pediatric Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524525000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524525000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:42:26Z","timestamp":1756658546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891524525000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0891524525000793"],"URL":"https:\/\/doi.org\/10.1016\/j.pedhc.2025.03.008","relation":{},"ISSN":["0891-5245"],"issn-type":[{"type":"print","value":"0891-5245"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissolved Bictegravir\/Emtricitabine\/Tenofovir Alafenamide Improves Medication Adherence","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Health Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedhc.2025.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of National Association of Pediatric Nurse Practitioners.","name":"copyright","label":"Copyright"}]}}